In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer’s ...

An ambitious plan to stop the global threat of AIDS has been derailed. But many are hopeful that progress can be salvaged.

A common medication used to treat HIV and hepatitis B may offer unexpected protection against Alzheimer's disease.

It's credited as the largest commitment by any country to fight a single disease in history ... a dose of antiretroviral ARV drugs used to prevent HIV from replicating, at the Nyumbani ...

People taking drugs for HIV and hepatitis B are less likely to develop Alzheimer’s disease, according to a new study. UVA Health investigators now would like clinical trials to examine the potential ...

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...